Insider Trading & Ownership of Southpoint Capital Advisors LP

Notable person
John S. Clark II
Location
New York, NY
Summary
The estimated value of insider holdings of Southpoint Capital Advisors LP is at least $20,585,557 dollars as of 29 Dec 2025. Southpoint Capital Advisors LP is the 10%+ Owner of FENNEC PHARMACEUTICALS INC. and owns shares of FENNEC PHARMACEUTICALS INC. (FENC) stock worth about $20.59M.
Signature
s/ John S. Clark II, Southpoint Capital Advisors LP, by Southpoint Capital Advisors LLC, its General Partner, by John S. Clark II, Managing Member
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Southpoint Capital Advisors LP and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Southpoint Capital Advisors LP has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $20,585,557.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: FENNEC PHARMACEUTICALS INC. ($20,585,557).
  • Past-year value change for that position: -$10,341,902.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Southpoint Capital Advisors LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
FENC FENNEC PHARMACEUTICALS INC. 10%+ Owner $20,585,557 -$10,341,902 -33% 24 Dec 2025

Insider Transactions Reported by Southpoint Capital Advisors LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored